Condition: Geographic Atrophy (GA) · Age - Related Macular Degeneration (AMD) · Sponsor: ONL Therapeutics
The purpose of this study is to collect efficacy and safety information of intravitreal injection for 3 experimental arms, including 2 dose levels of ONL1204 and 2 treatment frequencies in patients with GA associated with AMD. GA associated with AMD is one of the world's leading causes of visual disability and legal blindness globally. Associated with aging, cigarette smoking, obesity, diets low in certain nutrients, a lifestyle related to cardiac risk, and a growing list of genetic factors, AMD is becoming an increasingly prevalent public health concern, especially as the global population ages. ONL1204 is a first-in-class inhibitor of fragment apoptosis stimulator receptor-mediated cell death that has demonstrated protection of multiple retinal cell types in numerous preclinical models of retinal disease, including models of dry AMD.
This description comes directly from the study's public registry record.
Study Coordinator · 734-412-8787 · info@onltherapeutics.com
Always discuss trial participation with your own doctor first.
| Associated Retina Consultants | Gilbert, Arizona, United States | Recruiting |
| Associated Retina Consultants | Phoenix, Arizona, United States | Recruiting |
| California Retina Consultants | Bakersfield, California, United States | Recruiting |
| Retina-Vitreous Associates Medical Group | Beverly Hills, California, United States | Recruiting |
| Macula and Retina Institute | Glendale, California, United States | Recruiting |
| Salehi Retina Institute, dba Retina Associates of Southern California | Huntington Beach, California, United States | Recruiting |
| Desert Retina Consultants | Palm Desert, California, United States | Recruiting |
| Retinal Consultants Medical Group | Sacramento, California, United States | Recruiting |
| Bay Area Retina Associates | Walnut Creek, California, United States | Recruiting |
| Retina Consultants of Southern Colorado | Colorado Springs, Colorado, United States | Recruiting |
| Retina Group of New England | Waterford, Connecticut, United States | Recruiting |
| Florida Retina Institute | Orlando, Florida, United States | Recruiting |
+ 45 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06659445